Reactive oxygen species in in vitro pesticide-induced neuronal cell (SH-SY5Y) cytotoxicity: Role of NFκB and caspase-3

Free Radical Biology and Medicine

Volumn 42, Issue 2, 2007, Pages 288-298

  Jia, Zhenquan ^a   Misra, Hara P ^a  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Caspase 3; Catalase; Endosulfan; Free radicals; Glutathione peroxidase; Neuronal cell; NF B; Oxidative stress; Pesticides; Reactive oxygen species; Superoxide dismutase; Zineb

Indexed keywords

CASPASE 3; CATALASE; ENDOSULFAN; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID PEROXIDE; PESTICIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ZINEB;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; NERVE CELL LESION; NEUROTOXICITY; OXIDATIVE STRESS; PESTICIDE SPRAYING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CASPASE 3; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOSULFAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROGEN PEROXIDE; NEURONS; NF-KAPPA B; OXIDATIVE STRESS; PESTICIDES; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TIME FACTORS; ZINEB;

EID: 33845791439     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.10.047     Document Type: Article

References (127)

1. Leenders K.L., and Oertel W.H. Parkinson's disease: clinical signs and symptoms, neural mechanisms, positron emission tomography, and therapeutic interventions. Neural. Plast. 8 (2001) 99-110
2. Sandyk R., Bamford C.R., and Iacono R.P. Pain and sensory symptoms in Parkinson's disease. Int. J. Neurosci. 39 (1988) 15-25
3. Semchuk K.M., Love E.J., and Lee R.G. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42 (1992) 1328-1335
4. Butterfield P.G., Valanis B.G., Spencer P.S., Lindeman C.A., and Nutt J.G. Environmental antecedents of young-onset Parkinson's disease. Neurology 43 (1993) 1150-1158
5. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., and Richardson R.J. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50 (1998) 1346-1350
6. Ritz B., Yu F., Chapa G., and Fruin S. Effect of air pollution on preterm birth among children born in Southern California between 1989 and 1993. Epidemiology 11 (2000) 502-511
7. Jia Z., and Misra H.P. Developmental exposure to pesticides zineb and/or endosulfan renders the nigrostriatal dopamine system more susceptible to these environmental chemicals later in life. Neurotoxicology (2006) (under review)
8. Pokharkar D.S., and Dethe M.D. Gas-liquid chromatographic studies on residues of endosulfan on chilli fruits. J. Environ. Sci. Health, B 16 (1981) 439-451
9. Chugh S.N., Dhawan R., Agrawal N., and Mahajan S.K. Endosulfan poisoning in Northern India: a report of 18 cases. Int. J. Clin. Pharmacol. Ther. 36 (1998) 474-477
10. Aleksandrowicz D.R. Endosulfan poisoning and chronic brain syndrome. Arch. Toxicol. 43 (1979) 65-68
11. Blanco-Coronado J.L., Repetto M., Ginestal R.J., Vicente J.R., Yelamos F., and Lardelli A. Acute intoxication by endosulfan. J. Toxicol. Clin. Toxicol. 30 (1992) 575-583
12. Boereboom F.T., Van Dijk A., Van Zoonen P., and Meulenbelt J. Nonaccidental endosulfan intoxication: a case report with toxicokinetic calculations and tissue concentrations. J. Toxicol. Clin. Toxicol. 36 (1998) 345-352
13. Boyd E.M., and Dobos I. Protein deficiency and tolerated oral doses of endosulfan. Arch. Int. Pharmacodyn. Ther. 178 (1969) 152-165
14. Boyd E.M., Dobos I., and Krijnen C.J. Endosulfan toxicity and dietary protein. Arch. Environ. Health 21 (1970) 15-19
15. Gilbert M.E., and Mack C.M. Seizure thresholds in kindled animals are reduced by the pesticides lindane and endosulfan. Neurotoxicol. Teratol. 17 (1995) 143-150
16. Lakshmana M.K., and Raju T.R. Endosulfan induces small but significant changes in the levels of noradrenaline, dopamine and serotonin in the developing rat brain and deficits in the operant learning performance. Toxicology 91 (1994) 139-150
17. Paul V., Balasubramaniam E., Jayakumar A.R., and Kazi M. A sex-related difference in the neurobehavioral and hepatic effects following chronic endosulfan treatment in rats. Eur. J. Pharmacol. 293 (1995) 355-360
18. Ferraz H.B., Bertolucci P.H., Pereira J.S., Lima J.G., and Andrade L.A. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 38 (1988) 550-553
19. Mcgrew D.M., Irwin I., and Langston J.W. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice. Neurotoxicology 21 (2000) 309-312
20. Zhang J., Fitsanakis V.A., Gu G., Jing D., Ao M., Amarnath V., and Montine T.J. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J. Neurochem. 84 (2003) 336-346
21. Takahashi R.N., Rogerio R., and Zanin M. Maneb enhances MPTP neurotoxicity in mice. Res. Commun. Chem. Pathol. Pharmacol. 66 (1989) 167-170
22. Thiruchelvam M., Brockel B.J., Richfield E.K., Baggs R.B., and Cory-Slechta D.A. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?. Brain Res. 873 (2000) 225-234
23. Thiruchelvam M., Mccormack A., Richfield E.K., Baggs R.B., Tank A.W., Di Monte D.A., and Cory-Slechta D.A. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur. J. Neurosci. 18 (2003) 589-600
24. Thiruchelvam M., Richfield E.K., Goodman B.M., Baggs R.B., and Cory-Slechta D.A. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23 (2002) 621-633
25. Soleo L., Defazio G., Scarselli R., Zefferino R., Livrea P., and Foa V. Toxicity of fungicides containing ethylene-bis-dithiocarbamate in serumless dissociated mesencephalic-striatal primary coculture. Arch. Toxicol. 70 (1996) 678-682
26. Jia Z., and Misra H.P. Exposure to mixture of endosulfan and zineb induces apoptotic cell death in neuronal cells (SH-SY5Y), in vitro. NeuroToxicology 27 (2006) 924
27. Kitazawa M., Anantharam V., and Kanthasamy A.G. Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic. Biol. Med. 31 (2001) 1473-1485
28. Kitazawa M., Anantharam V., and Kanthasamy A.G. Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 119 (2003) 945-964
29. Rought S.E., Yau P.M., Guo X.W., Chuang L.F., Doi R.H., and Chuang R.Y. Modulation of CPP32 activity and induction of apoptosis in Human CEM X 174 lymphocytes by heptachlor, a chlorinated hydrocarbon insecticide. J. Biochem. Mol. Toxicol. 14 (2000) 42-50
30. Higuchi M., Honda T., Proske R.J., and Yeh E.T. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 17 (1998) 2753-2760
31. Gotz M.E., Kunig G., Riederer P., and Youdim M.B. Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 63 (1994) 37-122
32. Zhang Y., Dawson V.L., and Dawson T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7 (2000) 240-250
33. Owen A.D., Schapira A.H., Jenner P., and Marsden C.D. Oxidative stress and Parkinson's disease. Ann. N.Y. Acad. Sci. 786 (1996) 217-223
34. Jenner P., Dexter D.T., Sian J., Schapira A.H., and Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The royal kings and queens parkinson's disease research group. Ann. Neurol. 32 Suppl. (1992) S82-S87
35. Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta Neurol. Scand., Suppl. 136 (1991) 6-15
36. Christen Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71 (2000) 621S-629S
37. Pratico D., Clark C.M., Liun F., Rokach J., Lee V.Y., and Trojanowski J.Q. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 59 (2002) 972-976
38. Rottkamp C.A., Nunomura A., Raina A.K., Sayre L.M., Perry G., and Smith M.A. Oxidative stress, antioxidants, and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 14 Suppl. 1 (2000) S62-S66
39. Zafrilla P., Mulero J., Xandri J.M., Santo E., Caravaca G., and Morillas J.M. Oxidative stress in Alzheimer patients in different stages of the disease. Curr. Med. Chem. 13 (2006) 1075-1083
40. Bagchi D., Balmoori J., Bagchi M., Ye X., Williams C.B., and Stohs S.J. Role of p53 tumor suppressor gene in the toxicity of TCDD, endrin, naphthalene, and chromium (VI) in liver and brain tissues of mice. Free Radic. Biol. Med. 28 (2000) 895-903
41. Bachowski S., Xu Y., Stevenson D.E., Walborg Jr. E.F., and Klaunig J.E. Role of oxidative stress in the selective toxicity of dieldrin in the mouse liver. Toxicol. Appl. Pharmacol. 150 (1998) 301-309
42. Gauthier M., Roberge C.J., Pelletier M., Tessier P.A., and Girard D. Activation of human neutrophils by technical toxaphene. Clin. Immunol. 98 (2001) 46-53
43. Zhou Y., Shie F.S., Piccardo P., Montine T.J., and Zhang J. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience 128 (2004) 281-291
44. Fitsanakis V.A., Amarnath V., Moore J.T., Montine K.S., Zhang J., and Montine T.J. Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides. Free Radic. Biol. Med. 33 (2002) 1714-1723
45. Hincal F., Gurbay A., and Giray B. Induction of lipid peroxidation and alteration of glutathione redox status by endosulfan. Biol. Trace Elem. Res. 47 (1995) 321-326
46. Sohn H.Y., Kwon C.S., Kwon G.S., Lee J.B., and Kim E. Induction of oxidative stress by endosulfan and protective effect of lipid-soluble antioxidants against endosulfan-induced oxidative damage. Toxicol. Lett. 151 (2004) 357-365
47. Kannan K., Holcombe R.F., Jain S.K., Alvarez-Hernandez X., Chervenak R., Wolf R.E., and Glass J. Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line. Mol. Cell Biochem. 205 (2000) 53-66
48. Dorval J., and Hontela A. Role of glutathione redox cycle and catalase in defense against oxidative stress induced by endosulfan in adrenocortical cells of rainbow trout (Oncorhynchus mykiss). Toxicol. Appl. Pharmacol. 192 (2003) 191-200
49. Dorval J., Leblond V.S., and Hontela A. Oxidative stress and loss of cortisol secretion in adrenocortical cells of rainbow trout (Oncorhynchus mykiss) exposed in vitro to endosulfan, an organochlorine pesticide. Aquat. Toxicol. 63 (2003) 229-241
50. Pandey S., Ahmad I., Parvez S., Bin-Hafeez B., Haque R., and Raisuddin S. Effect of endosulfan on antioxidants of freshwater fish Channa punctatus Bloch: 1. Protection against lipid peroxidation in liver by copper preexposure. Arch. Environ. Contam. Toxicol. 41 (2001) 345-352
51. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
52. Guerrini L., Blasi F., and Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9077-9081
53. Nebot C., Moutet M., Huet P., Xu J.Z., Yadan J.C., and Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal. Biochem. 214 (1993) 442-451
54. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
55. Beers Jr. R.F., and Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195 (1952) 133-140
56. Thornberry N.A. Interleukin-1 beta converting enzyme. Methods Enzymol. 244 (1994) 615-631
57. Shen H.M., Shi C.Y., Shen Y., and Ong C.N. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic. Biol. Med. 21 (1996) 139-146
58. Matsura T., Kai M., Fujii Y., Ito H., and Yamada K. Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Radic Res. 30 (1999) 73-83
59. Przedborski S., Tieu K., Perier C., and Vila M. MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenerg. Biomembr. 36 (2004) 375-379
60. Shimoke K., Kudo M., and Ikeuchi T. MPTP-induced reactive oxygen species promote cell death through a gradual activation of caspase-3 without expression of GRP78/Bip as a preventive measure against ER stress in PC12 cells. Life Sci. 73 (2003) 581-593
61. Mccarthy S., Somayajulu M., Sikorska M., Borowy-Borowski H., and Pandey S. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. Toxicol. Appl. Pharmacol. 201 (2004) 21-31
62. Huang T.T., Yasunami M., Carlson E.J., Gillespie A.M., Reaume A.G., Hoffman E.K., Chan P.H., Scott R.W., and Epstein C.J. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch. Biochem. Biophys. 344 (1997) 424-432
63. Peng J., Mao X.O., Stevenson F.F., Hsu M., and Andersen J.K. The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J. Biol. Chem. 279 (2004) 32626-32632
64. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J.A., and Robinson J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278 (2003) 8516-8525
65. Pahlman S., Mamaeva S., Meyerson G., Mattsson M.E., Bjelfman C., Ortoft E., and Hammerling U. Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand., Suppl. 592 (1990) 25-37
66. Lennon S.V., Martin S.J., and Cotter T.G. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 24 (1991) 203-214
67. Escargueil-Blanc I., Salvayre R., and Negre-Salvayre A. Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells. FASEB J. 8 (1994) 1075-1080
68. Gardner A.M., Xu F.H., Fady C., Jacoby F.J., Duffey D.C., Tu Y., and Lichtenstein A. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med. 22 (1997) 73-83
69. Valencia A., and Moran J. Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Radic. Biol. Med. 36 (2004) 1112-1125
70. Cole K.K., and Perez-Polo J.R. Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H(2)O(2) injury. J. Neurochem. 82 (2002) 19-29
71. Feierman D.E., Winston G.W., and Cederbaum A.I. Ethanol oxidation by hydroxyl radicals: role of iron chelates, superoxide, and hydrogen peroxide. Alcohol Clin. Exp. Res. 9 (1985) 95-102
72. Jackson J.H., Gajewski E., Schraufstatter I.U., Hyslop P.A., Fuciarelli A.F., Cochrane C.G., and Dizdaroglu M. Damage to the bases in DNA induced by stimulated human neutrophils. J. Clin. Invest. 84 (1989) 1644-1649
73. Zhou L.Z., Johnson A.P., and Rando T.A. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 31 (2001) 1405-1416
74. Thiruchelvam M., Prokopenko O., Cory-Slechta D.A., Richfield E.K., Buckley B., and Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J. Biol. Chem. 280 (2005) 22530-22539
75. Bebe F.N., and Panemangalore M. Exposure to low doses of endosulfan and chlorpyrifos modifies endogenous antioxidants in tissues of rats. J. Environ. Sci. Health, B 38 (2003) 349-363
76. Maitre B., Jornot L., and Junod A.F. Effects of inhibition of catalase and superoxide dismutase activity on antioxidant enzyme mRNA levels. Am. J. Physiol. 265 (1993) L636-L643
77. Perandones C.E., Illera V.A., Peckham D., Stunz L.L., and Ashman R.F. Regulation of apoptosis in vitro in mature murine spleen T cells. J. Immunol. 151 (1993) 3521-3529
78. Djordjevic V.B. Free radicals in cell biology. Int. Rev. Cytol. 237 (2004) 57-89
79. Reiter R.J., Acuna-Castroviejo D., Tan D.X., and Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann. N.Y. Acad. Sci. 939 (2001) 200-215
80. Marnett L.J. Chemistry and biology of DNA damage by malondialdehyde. IARC Sci. Publ. 150 (1999) 17-27
81. Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 424 (1999) 83-95
82. Mutlu-Turkoglu U., Ilhan E., Oztezcan S., Kuru A., Aykac-Toker G., and Uysal M. Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin. Biochem. 36 (2003) 397-400
83. Kedziora-Kornatowska K.Z., Luciak M., and Paszkowski J. Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life 49 (2000) 303-307
84. Requena J.R., Fu M.X., Ahmed M.U., Jenkins A.J., Lyons T.J., and Thorpe S.R. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 11 Suppl. 5 (1996) 48-53
85. Agarwal D.K., Seth P.K., and Gupta P.K. Effect of endosulfan on drug metabolizing enzymes and lipid peroxidation in rat. J. Environ. Sci. Health, C 13 (1978) 49-62
86. Ayub S., Verma J., and Das N. Effect of endosulfan and malathion on lipid peroxidation, nitrite and TNF-alpha release by rat peritoneal macrophages. Int. Immunopharmacol. 3 (2003) 1819-1828
87. Narayan S., Bajpai A., Chauhan S.S., and Misra U.K. Lipid peroxidation in lung and liver of rats given DDT and endosulfan intratracheally. Bull. Environ. Contam. Toxicol. 34 (1985) 63-67
88. Singh S.K., and Pandey R.S. Toxicity of endosulfan on kidney of male rats in relation to drug metabolizing enzymes and microsomal lipid peroxidation. Indian J. Exp. Biol. 27 (1989) 725-728
89. Patel S., Singh V., Kumar A., Gupta Y.K., and Singh M.P. Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: Mechanism of neurodegeneration. Brain Res. 1081 (2006) 9-18
90. Shimohama S., Tanino H., and Fujimoto S. Differential expression of rat brain caspase family proteins during development and aging. Biochem. Biophys. Res. Commun. 289 (2001) 1063-1066
91. Yakovlev A.G., Ota K., Wang G., Movsesyan V., Bao W.L., Yoshihara K., and Faden A.I. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J. Neurosci. 21 (2001) 7439-7446
92. De Bilbao F., Guarin E., Nef P., Vallet P., Giannakopoulos P., and Dubois-Dauphin M. Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study. J. Comp. Neurol. 409 (1999) 339-357
93. + -induced apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 55 (1999) 620-628
94. Jellinger K.A. Cell death mechanisms in Parkinson's disease. J. Neural Transm. 107 (2000) 1-29
95. Jordan J., Galindo M.F., Cena V., and Gonzalez-Garcia C. [Cysteine proteinase and neurodegeneration]. Rev. Neurol. 31 (2000) 333-340
96. Rideout H.J., and Stefanis L. Caspase inhibition: a potential therapeutic strategy in neurological diseases. Histol. Histopathol. 16 (2001) 895-908
97. Stadelmann C., Deckwerth T.L., Srinivasan A., Bancher C., Bruck W., Jellinger K., and Lassmann H. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am. J. Pathol. 155 (1999) 1459-1466
98. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G.I., Agid Y., and Hirsch E.C. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2875-2880
99. Raffray M., and Cohen G.M. Bis(tri-n-butyltin)oxide induces programmed cell death (apoptosis) in immature rat thymocytes. Arch. Toxicol. 65 (1991) 135-139
100. Wyllie A.H. Apoptosis: cell death under homeostatic control. Arch. Toxicol., Suppl. 11 (1987) 3-10
101. Bowie A. O'neill, L. A. Oxidative stress and NF-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 (2000) 13-23
102. Foncea R., Carvajal C., Almarza C., and Leighton F. Endothelial cell oxidative stress and signal transduction. Biol. Res. 33 (2000) 89-96
103. Schreck R., Albermann K., and Baeuerle P.A. NF-κB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17 (1992) 221-237
104. Dolcet X., Llobet D., Pallares J., and Matias-Guiu X. NF-κB in development and progression of human cancer. Virchows Arch. 446 (2005) 475-482
105. Feinman R., Siegel D.S., and Berenson J. Regulation of NF-κB in multiple myeloma: therapeutic implications. Clin. Adv. Hematol. Oncol. 2 (2004) 162-166
106. Giuliani C., Napolitano G., Bucci I., Montani V., and Monaco F. NF-κB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications. Clin. Ter. 152 (2001) 249-253
107. Wooten M.W. Function for NF-κB in neuronal survival: regulation by atypical protein kinase C. J. Neurosci. Res. 58 (1999) 607-611
108. Muller J.M., Rupec R.A., and Baeuerle P.A. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 11 (1997) 301-312
109. Schulze-Osthoff K., Los M., and Baeuerle P.A. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem. Pharmacol. 50 (1995) 735-741
110. Cahill M.A., Peter M.E., Kischkel F.C., Chinnaiyan A.M., Dixit V.M., Krammer P.H., and Nordheim A. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 13 (1996) 2087-2096
111. Johnson N.L., Gardner A.M., Diener K.M., Lange-Carter C.A., Gleavy J., Jarpe M.B., Minden A., Karin M., Zon L.I., and Johnson G.L. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J. Biol. Chem. 271 (1996) 3229-3237
112. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
113. Jang J.H., and Surh Y.J. Bcl-2 attenuation of oxidative cell death is associated with up-regulation of gamma-glutamylcysteine ligase via constitutive NF-κB activation. J. Biol. Chem. 279 (2004) 38779-38786
114. Shin M.H., Jang J.H., and Surh Y.J. Potential roles of NF-κB and ERK1/2 in cytoprotection against oxidative cell death induced by tetrahydropapaveroline. Free Radic. Biol. Med. 36 (2004) 1185-1194
115. Lee Y.J., Kang I.J., Bunger R., and Kang Y.H. Enhanced survival effect of pyruvate correlates MAPK and NF-κB activation in hydrogen peroxide-treated human endothelial cells. J. Appl. Physiol. 96 (2004) 793-801 discussion 792
116. Kang K.S., Park J.E., Ryu D.Y., and Lee Y.S. Effects and neuro-toxic mechanisms of 2, 2′, 4, 4′, 5, 5′-hexachlorobiphenyl and endosulfan in neuronal stem cells. J. Vet. Med. Sci. 63 (2001) 1183-1190
117. Kremers P. In vitro tests for predicting drug-drug interactions: the need for validated procedures. Pharmacol. Toxicol. 91 (2002) 209-217
118. Kremers P. Can drug-drug interactions be predicted from in vitro studies?. ScientificWorldJournal 2 (2002) 751-766
119. Ross R.A., and Biedler J.L. Expression of a melanocyte phenotype in human neuroblastoma cells in vitro. Prog. Clin. Biol. Res. 175 (1985) 249-259
120. Pahlman S., Ruusala A.I., Abrahamsson L., Mattsson M.E., and Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ. 14 (1984) 135-144
121. Biedler J.L., Roffler-Tarlov S., Schachner M., and Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38 (1978) 3751-3757
122. Rowles T.K., Song X., and Ehrich M. Identification of endpoints affected by exposure of human neuroblastoma cells to neurotoxicants at concentrations below those that affect cell viability. In vitro Toxicol. 1 (1995) 1-11
123. Adem A., Mattsson M.E., Nordberg A., and Pahlman S. Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res. 430 (1987) 235-242
124. Schmuck K., Ullmer C., Engels P., and Lubbert H. Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS Lett. 342 (1994) 85-90
125. Marinovich M., Viviani B., Capra V., Corsini E., Anselmi L., D'Agostino G., Di Nucci A., Binaglia M., Tonini M., and Galli C.L. Facilitation of acetylcholine signaling by the dithiocarbamate fungicide propineb. Chem. Res. Toxicol. 15 (2002) 26-32
126. Carlson K., Jortner B.S., and Ehrich M. Organophosphorus compound-induced apoptosis in SH-SY5Y human neuroblastoma cells. Toxicol. Appl. Pharmacol. 168 (2000) 102-113
127. Skandrani D., Gaubin Y., Beau B., Murat J.C., Vincent C., and Croute F. Effect of selected insecticides on growth rate and stress protein expression in cultured human A549 and SH-SY5Y cells. Toxicol. In Vitro (2006)